Joint statement from the EAU and IKCC about the rejection of the ipilimumab plus nivolumab combination for kidney cancer by the EMA
The European Association of Urology (EAU) Renal Cell Cancer Guidelines [...]
The European Association of Urology (EAU) Renal Cell Cancer Guidelines [...]
The International Kidney Cancer Coalition (IKCC) have released the following [...]
These short videos explain the latest results from the following [...]
Yesterday it was announced that the combination of ipilimumab and [...]
A recent meta-analysis evaluating the efficacy of first- and second-line [...]
The following interview with Dr Eric Jonasch, medical oncologist from [...]
Patient-reported outcomes data from the Phase 3 CheckMate-214 trial of [...]
The US Food and Drug Administration (FDA) has granted approval [...]
Overall survival data for the ipilimumab-nivolumab combination versus sunitinib from [...]
Further to the results from recent studies, particularly CheckMate-214, the [...]